XML 46 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Narrative) (Details)
$ / shares in Units, $ in Millions
9 Months Ended
Sep. 30, 2020
USD ($)
item
$ / shares
shares
Sep. 30, 2019
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of stock-based compensation plans | item 4  
Option expiration period 10 years  
Number of common stock reserved for issuance (in shares) 3,300,000  
Unrecognized compensation cost related to unvested awards under share-based plans | $ $ 13.4  
Cost expected to be recognized over a weighted average period 2 years 1 month 6 days  
Share-based Payment Arrangement, Expense | $ $ 5.1 $ 4.4
Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Granted (in shares) 1,531,702 930,831
Granted (in dollars per share) | $ / shares $ 6.87  
Options Granted (in dollars per share) | $ / shares   $ 8.57
Restricted Stock Units (RSUs) [Member] | Share-based Payment Arrangement, Tranche One [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vesting period 2 years 9 months 3 years
Granted (in shares) 1,387,602 863,331
Restricted Stock Units (RSUs) [Member] | Share-based Payment Arrangement, Tranche Two [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vesting period 1 year 1 year
Granted (in shares) 144,100 67,500
Stock Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Options Granted (in shares) 300,000 65,104
Vesting period 4 years 4 years
Stock option exercised (in shares) 74,000 0
Options Granted (in dollars per share) | $ / shares $ 3.02 $ 3.84
Options exercised and vested in period, total intrinsic value | $ $ 6.5 $ 4.3
Restricted Stock Units And Stock Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $ $ 5.3 $ 3.8